Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy
NCT05427214 is an interventional trial sponsored by Washington University School of Medicine. As of 21 Nov 2026, it is completed. It studies Brain Cancer, Colon Cancer and 4 more conditions. The registry lists an enrollment of 52 participants at 1 site in 1 country. The registry lists a start date of 19 Aug 2022 and a primary completion date of 17 Oct 2024. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT05427214 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Washington University School of Medicine |
| Enrollment | 52 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Brain Cancer, Colon Cancer, Gastric Cancer, Head and Neck Cancer, Lung Cancer, and Ovarian Cancer |
| Start | 19 Aug 2022 |
| Primary completion | 17 Oct 2024 |
| Study completion | 17 Oct 2024 |
| Last update posted | 21 Oct 2024 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Pamela Samson, M.D., MPHS
Washington University School of Medicine
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington University School of Medicine
St Louis
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT05427214
Each answer restates registry values shown on this page.
What is NCT05427214?
NCT05427214 is an interventional trial sponsored by Washington University School of Medicine. It studies Brain Cancer, Colon Cancer and 4 more conditions.
Who leads NCT05427214?
The registry names Pamela Samson, M.D., MPHS (principal investigator, Washington University School of Medicine) as the overall official.
Where does NCT05427214 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT05427214 end?
The registry lists a primary completion date of 17 Oct 2024 and a study completion date of 17 Oct 2024. The sponsor last updated the record on 21 Oct 2024.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.